Nova Satra Dx Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$12M
- Investors
-
1
Nova Satra Dx General Information
Description
Developer of molecular diagnostic cancer tests designed to improve lives through cancer detection. The company's blood-based diagnostic tests leverage epigenetic platform technology for testing breast cancer using stable DNA-based targets as part of chromosomal signatures, enabling healthcare providers to accurately diagnose and detect cancer at earlier stages.
Contact Information
Website
www.novasatra.comCorporate Office
- 1 Science Park Road
- 04-10 The Capricorn Science Park I
- Singapore, 117528
- Singapore
Corporate Office
- 1 Science Park Road
- 04-10 The Capricorn Science Park I
- Singapore, 117528
- Singapore
Nova Satra Dx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 22-Aug-2019 | $12M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 29-Mar-2017 | Completed | Startup |
Nova Satra Dx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Nova Satra Dx Comparisons
Industry
Financing
Details
Nova Satra Dx Competitors (33)
One of Nova Satra Dx’s 33 competitors is Blueprint Genetics, a Formerly VC-backed company based in Espoo, Finland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Blueprint Genetics | Formerly VC-backed | Espoo, Finland | ||||
| Invitae | Formerly VC-backed | San Francisco, CA | ||||
| CellMax Life | Venture Capital-Backed | Sunnyvale, CA | ||||
| Natera | Formerly VC-backed | Austin, TX | ||||
| Biocept | Formerly VC-backed | San Diego, CA |
Nova Satra Dx Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Nova Satra Dx Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Genting Bio Cellular | Corporation | Minority |
Nova Satra Dx FAQs
-
Where is Nova Satra Dx headquartered?
Nova Satra Dx is headquartered in Singapore, Singapore.
-
What industry is Nova Satra Dx in?
Nova Satra Dx’s primary industry is Clinics/Outpatient Services.
-
Is Nova Satra Dx a private or public company?
Nova Satra Dx is a Private company.
-
What is the current valuation of Nova Satra Dx?
The current valuation of Nova Satra Dx is .
-
What is Nova Satra Dx’s current revenue?
The current revenue for Nova Satra Dx is .
-
How much funding has Nova Satra Dx raised over time?
Nova Satra Dx has raised $2M.
-
Who are Nova Satra Dx’s investors?
Genting Bio Cellular has invested in Nova Satra Dx.
-
Who are Nova Satra Dx’s competitors?
Blueprint Genetics, Invitae, CellMax Life, Natera, and Biocept are some of the 33 competitors of Nova Satra Dx.
-
When was Nova Satra Dx acquired?
Nova Satra Dx was acquired on 22-Aug-2019.
-
Who acquired Nova Satra Dx?
Nova Satra Dx was acquired by iNEX Innovate.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
